Form D · Biotechnology
PARLEY NEUROTECH INC
Denver, CO · CIK 0002137563
Offering snapshot reported Jun 17, 2026 · SEC filing
- Reported sold
- $140K Offering amount: $300K
- Investors reported
- 3 Form D · investor count
- Minimum accepted
- $5K Reported outside-investor minimum
- First sale
- Jun 12, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Jun 17, 2026 | Initial | $140,000 | No comparison | 3 | SEC filing |
Offering details
- Securities
- Equity
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-587630
Offering consists of SAFE notes capped at $300,000 in a friends and family round.
Source: Form D, filed Jun 17, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Samuel Alexander Budoff | Executive |
| Achim Egbert Klug | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
3000 Lawrence St
Denver, CO, 80205
Denver, CO, 80205